Only pumps PSTI, nobody else. If she was such a guru, then why not write articles for other breakout opportunities? She is one dimensional. Like alpo, she has good points and can be a stream of information, but like alpo, her act gets old. Such a great resume, but no credibility. Tsk, tsk, girlfriends......
Sharon has lost all credibility. Where she used to raise the sock 3-6%, she now only provides endless pumps with no rationality to the downside. As much as the stock could go up, there is also a chance it may recede as their products are only in preliminary stages and they will need cash soon. Pay attention folks.
Bump all you want, still pre-clinical.
Please share why you believe that, but also, please keep it on an intellectual level if you can. Keep conjecture for what it is, opinions based upon incomplete information.
There is no controller. The term was once brought up by another poster and now Allo and her cohorts have adopted it as their own, making people believe in their ranting's. It needs to go by the wayside along with "selfie".
The stock goes up on news, down as sellers take profits, back up on news, down with the swing traders, just like all stocks. It is being traded in a tight range but only because real investors and tutes have very little interest in where the company stands at this point. There are no long term players on board yet. Traders, such as Allo's company, are the only ones who are actually buying, only to sell bits and pieces a day or two after news. Again, no controller. Yikes!
Wow...I just did the math. Almost 2 million shares were issued (exercised cash & cashless warrants) which generated $1.179M in "financing". That equates to ~.605 per share. I overlooked that one until now. Shakin' my head.
The shares outstanding grew almost 9% during 2H13, primarily due the 2,5M shares given to Cha plus another 2M in exercised warrants and 750K in employee compensation. Now around 64M and change.
The ATM is in affect for another 1.75 years and any shares randomly sold into the market need only be reported on the 10Q. As none were reported for 4Q, we will wait until 1Q14 is released in 2 months time.
Gee, does anyone else here think Buteo & allo are the same person? It's pretty evident.
The real tragedy is the deaths happened to coincide with the offering. If anyone believes Zami didn't know about these is wearing rose colored glasses. His only option was to lie, saying he didn't know as they weren't following the patients' progresses, or they would lose $20-$30M in cash. Seriously, what would you do in that situation? I also find it interesting how he nonchalantly mentioned the second death in his rebuttal. He seemed to know about that one. Yes, the lives were extended for a period of time, but the fact is 2 of 3 died and the company went silent.
CHA took a very small risk with PSTI. It was a stock swap and a formed joint venture upon approval, nothing more Who knows how long it will be before they start their first trial. United waited 2 years and extended their agreement another 3 years. Very little has happened on this front and CHA may decide to proceed in a similar fashion. There is no time line for them and they will invest in the trials when they see fit. As of today, they have invested $0 and diluted shareholders of both companies. And to allo, yes, they did get SK approval for their protocol, but that's it, my friends.
Dilution is inevitable. This company is no less than 3 years away from marketing their technology for any indication. Their lead candidate is midway through Phase II and will need to complete a longer PHIII when the results come back. The hip injury recently finished Phase I/II but will need to begin their Phase 2b trials and more, not to mention this is only being conducted in Germany. Preeclampsia is still in its infancy stage as are their many other indications. There will be hundreds of millions of dollars needed to complete these researches. Any partnership in this day and age won't put that kind of money up front. There will be milestone payments down the road, but the real money doesn't roll in until the drug is available to the public. How much have they received from United since 2011? Not enough.
The tricky part here is the ATM. Up to $90M can be put on the open market at anytime without notice. Now I'm not sure when they need to report any ATM activity, but it is definitely after the fact and can be done with a clandestine SEC filing. Very simple. Heck, they could have diluted another 10% and we may not find out until the 10K in 2 months. (If anybody knows the correct rules of ATM reporting, please share.) It would be nice to see the Baker Brothers, FMI, New Leaf or any big name firm jump on board & take some ownership here. I still can't figure why they can't sell this breakthrough technology to the investment community. Dilution is not a matter of if, but rather when and how.